Be part of a premier scientific event hosted by NATA, the leading society in Patient Blood Management (PBM), Haemostasis, and Thrombosis. This congress gathers top experts, researchers, and industry leaders to advance knowledge, innovation, and collaboration in these critical fields.
Why Participate?
AIFA PROCEDURE for Italian Pharmaceuticals
The agency officially entitled for the AIFA procedure of NATA Annual Symposium is the following:
FARGO INTERNATIONAL di Giulia Cambria
Via Pietro Maroncelli, 32
50137 Firenze
P.Iva 07325650484
The first deadline for the AIFA pre-request is: FEBRUARY 14th 2025
NATA25 (EMT-24-01332) has been determined as compliant with MedTech Europe Code of Ethical Business Practice and EFPIA Code of Practice.
We would like to thank the following companies for their support and participation.
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther healthcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.